Long-term cardiac effects of modern treatment for Hodgkin's lymphoma.
Anders W BjerringKnut Hb SmelandThomas StokkeKristina H HaugaaEspen HolteAssami RösnerCecilie E KiserudThor EdvardsenSebastian Imre Sarvari
Published in: Cardio-oncology (London, England) (2024)
HLS treated with anthracyclines after the late 1990s have similar cardiac function and morphology as age-matched controls, apart from higher rates of valvular disease in those who also underwent mediastinal radiotherapy.